Page 62 - IMR Annual Report 2022: Institute for Medical Research
P. 62

IMR Annual
              46
                      Report2022
                              INSTITUTE FOR MEDICAL RESEARCH



                                                                                             Principal
                    No.                 Research Title                    NMRR             investigator/
                                                                         Number            Co-principal
                                                                                       investigator (Co-PI)
                     35    Comparison of EMJH, EMJH-STAFF, EMJH-       RSCH ID-21-     Dr. Mohammad
                           5FU, HAN and LVW for cultivation and         01134-OK8      Ridhuan Mohd Ali
                           maintenance of pathogenic  Leptospira
                           strains

                     36    Improving the TRIcycle protocol: upscaling   RSCH ID-22-    Dr. Rohaidah Hashim
                           to national monitoring and detection of      00996-SDM
                           extended spectrum beta lactamase  E. coli
                           (ESBL-Ec) and carbapenemase producer
                           E. coli and  Enterobacterales (CPE) and
                           WGS pipelines for one health surveillance
                           (TRIUMPH)
                     37    Utility of PCR for the diagnosis of septic   NMRR ID-22-    Dr. Mohammad
                           patients with negative blood culture         00092-A6H      Ridhuan Mohd Ali
                     38    Design and development of high affinity DNA   NMRR-21-      Dr. Siti Khairani Mohd
                           aptamers for detection of Corynebacterium     879-59651     Hafiz Ngoo
                           diphtheriae exotoxin for future point-of-care
                           testing

                     39    To study the antibiotic resistance mechanisms   NMRR-21-    Shirley Hii Yi Fen
                           involved in different colony morphotypes of   1815-61436
                           Burkholderia pseudomallei to ceftazidime
                           and trimethoprim-sulfamethoxazole
                     40    Prevalence and characteristics of tuberculous   NMRR-21-    Dr. Saraswathiy
                           meningitis in Malaysia 2015-2020              02308-I2N     Maniam
                     41    Isolation  and  propagation  of  Orientia     NMRR-21-      Tay Bee Yong
                           tsutsugamushi (strain Karp, Kato and Gilliam)   922-59874
                           and  Rickettsia  typhi  in  different  types  of
                           mammalian cell lines
                     42    Seropositivity of  Bartonella henselae in     NMRR-22-      Dr. Noraliza Binti
                           cat scratch disease suspected patients in       00585       Zabari
                           Malaysian population: A 5-year study (2015-
                           2019)
                     43    Molecular characterization of multidrug       NMRR-21-      Nor Hazrin Binti Abd
                           resistant Salmonella enterica serovar typhi  1238-60040     Hazis
                     44    A   cross-sectional  study   on    clinical   NMRR-22-      Dr. Murnihayati Binti
                           characteristics and outcomes of patients     01290-TUD      Hassan
                           infected with  Candida haemolunii complex        IIR
                           and  the  related  species  in  Malaysia  from
            Infectious Diseases  Research Centre (IDRC)  45  Unusual case of  Mycobacterium marinum   NMRR ID-22-  Dr. Mohamad Hilmi
                           2019 to 2021

                                                                        01557-KXT
                           infection in Malaysia: A Case Report
                                                                                       Bin Abdul Razak
                           Discovering the mechanism of graphene-
                     46
                           based nanoparticles to enhance the activity
                                                                          2022-1
                           of isoniazid in antituberculosis therapy     USM-FRGS       Dr.  Azura Mohd Noor
   57   58   59   60   61   62   63   64   65   66   67